Sort
30,917 grants matching “tumor microenvironment”
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$563,282Kit S Lam · University Of California At Davis · U01 · FY2019 · CA
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
$563,237Wendell A Lim · University Of California, San Francisco · R01 · FY2025 · CA
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
$563,237Wendell A Lim · University Of California, San Francisco · R01 · FY2021 · CA
Targeting S1P-ACC Axis to Overcome MDSC Suppression
$563,233Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2025 · CA
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer
$563,228Kevin C Barry · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Mammalian Target of Rapamycin in Prostate Carcinogenesis
$562,905Jeffrey Michael Arbeit · Washington University · R01 · FY2007 · CA
Dual p300 and p53 reactivation in HPV+ head and neck cancer
$562,898Quintin Pan · Case Western Reserve University · R01 · FY2025 · DE
Spatially resolved, single cell biomarkers of B cell lymphoma
$562,886Akil Merchant · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Molecular Pathology of Cancer
$562,873Michael Emmert-Buck · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Image-guided combination therapy: noninvasive assessment of delivery and response
$562,844Dmitri Artemov · Johns Hopkins University · R01 · FY2015 · CA
The CCK-B receptor signaling pathway as a driver of pancreatic cellular plasticity and carcinogenesis
$562,784Jill P Smith · Georgetown University · R01 · FY2024 · CA
Defining mechanisms to promote antitumor immunity by modulating one-carbon metabolism
$562,761Arlene H Sharpe · Harvard Medical School · R01 · FY2025 · CA
CAREER: Mechanisms of Drug Resistance in a Responsive Biomaterial Platform
$562,743Shelly Peyton · University Of Massachusetts Amherst · · FY2015 · MPS
Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer
$562,656Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2022 · CA
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
$562,648Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U01 · FY2014 · CA
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$562,597Jin-Ming Yang · University Of Kentucky · R01 · FY2020 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2022 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2023 · CA
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic
$562,447David W. Clapp · Indiana University Indianapolis · U54 · FY2024 · CA
Znf740 in the regulation of CD8+T cell exhaustion
$562,412Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2025 · CA
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer
$562,338Evanthia Theodosiou Roussos Torres · University Of Southern California · R01 · FY2025 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer
$562,279Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Mechanism of Activity of Lonidamine
$562,245Jerry D Glickson · University Of Pennsylvania · R01 · FY2015 · CA
Characterize longitudinal events of oral high-risk human papillomavirus to alter risk for oropharyngeal cancer (CLEAR)
$562,100Rebecca G. Nowak · University Of Maryland Baltimore · R01 · FY2025 · DE
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments
$562,063David Kevin Wood · University Of Minnesota · R01 · FY2023 · CA